Listed

Tempest Therapeutics, Inc.: Form 10-Q for the period ended Jun 30, 2014

Filed with the SEC on Aug 7, 2014 and accepted by EDGAR at Aug 7, 2014, 09:05 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2014-04-01 to 2014-06-30$4.5mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2014-01-01 to 2014-06-30$9.2mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2014-04-01 to 2014-06-30$5.1mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2014-01-01 to 2014-06-30$8.1mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2014-04-01 to 2014-06-30−$9.6mus-gaap:OperatingIncomeLoss
Operating income6 months2014-01-01 to 2014-06-30−$17.2mus-gaap:OperatingIncomeLoss
Net income3 months2014-04-01 to 2014-06-30−$9.9mus-gaap:NetIncomeLoss
Net income6 months2014-01-01 to 2014-06-30−$17.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2014-04-01 to 2014-06-30−$0.42us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2014-01-01 to 2014-06-30−$0.83us-gaap:EarningsPerShareBasicAndDiluted
Capital expenditure6 months2014-01-01 to 2014-06-30$1.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2014-06-30$16.6mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-06-30$82.6mus-gaap:AssetsCurrent
Total assetsAt period end2014-06-30$85.8mus-gaap:Assets
Current liabilitiesAt period end2014-06-30$7.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-06-30$7.1mus-gaap:Liabilities
Shareholders' equityAt period end2014-06-30$78.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001104659-14-057930. Last ingested by Listed: Nov 15, 2026, 00:20 ET. Listed shows no prices and gives no investment advice.